Amed Co., Ltd. (TPEX:7575)

Market Cap	573.00M -49.9%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	30.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	1.50 (7.90%)
Ex-Dividend Date	Jun 16, 2025

Volume	29,000
Open	19.10
Previous Close	19.10
Day's Range	18.70 - 19.10
52-Week Range	18.40 - 36.90
Beta	-0.40
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Amed Co., Ltd.

Amed Co., Ltd. engages in the research and development, manufacture, and trading of medical equipment in Taiwan. It offers wound care dressing products under the HERADERM brand name; negative pressure wound therapy systems that provides 24-hour oxygen supply to wounds under the Genadyne brand name; and wound treatment systems under the Natrox brand name. The company also provides 7-day long-acting pain reliever injections under the Naldebain brand name. In addition, it offers pressure injectable implantable port kits under the POLYSITE brand; a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2008
• Employees: 165
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7575